You searched for "Training"
25-gauge PPV for retained lens fragments
This was a retrospective study including 40 eyes of 40 patients with mean age of 78 years, 19 females and 21 males, who underwent 25-gauge pars plana vitrectomy (PPV) for retained lens fragments with a minimum of six months of...
Screening accuracy
In this study the authors observed whether and how well orthoptic tests are performed by non-orthoptists in a screening setting. They assessed the quality of screening tests by semi-structured observations of youth health care (YHC) physicians who screened children aged...
Topical steroids and ptosis surgery
This is a retrospective review examining the effect of prior topical steroid use on patients undergoing ptosis surgery. Out of a total of 406 eyelids undergoing ptosis repairs, 44 had received topical steroids for an average of 3.7 years prior...
Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections
This multicentre study examining a five-year period from 2014 to 2018 evaluated the incidence rate and outcomes of endophthalmitis after intravitreal injection of in-house compounded bevacizumab. In-house compounded syringes were prepared in compounding pharmacy using sterile standard operating guidelines. All...
Cystoid macular oedema following retinal detachment surgery
There are limited studies examining the incidence and risk factors for postoperative cystoid macular oedema (CMO) following rhegmatogenous retinal detachment (RRD) repair. Postoperative CMO is thought to be due to pro-inflammatory state, where numerous cytokines lead to tight junction dysfunction,...
Two-year results of a T&E aflibercept regime in caucasian PNV
This a retrospective study examining two-year outcomes of patients with pachychoroid neovasculopathy (PNV) treated with a treat and extend (T&E) regimen of intravitreal aflibercept. The mean age was 63.84 ± 7.92 years with nine males (35%) and 17 females (65%)....End stage glaucoma management
A 48-year-old female has had multiple drug treatment for glaucoma and is still losing field of vision. How do you manage this over time? This patient is at high-risk for going blind and should be managed aggressively to protect remaining...
